Bosentan therapy for chronic thromboembolic pulmonary hypertension. A national open label study assessing the effect of Bosentan on haemodynamics, exercise capacity, quality of life, safety and tolerability in patients with chronic thromboembolic pulmonary hypertension (BOCTEPH-Study)
Gespeichert in:
Verfasser / Beitragende:
[S. Ulrich, R. Speich, G. Domenighetti, T. Geiser, J.D. Aubert, T. Rochat, L. Huber, U. Treder, M. Fischler]
Ort, Verlag, Jahr:
2007
Enthalten in:
Swiss medical weekly, 137/41-42(2007-10-20), 573-580
Format:
Artikel (online)